AI in Mental Health Market Analysis from 2022 to 2034 Containing Market Size, Share along with its CAGR, Forecast and Trends

Top Countries — Revenue

Million

Market Dynamics of AI in Mental Health Market Analysis

Growth Drivers

  • Increasing Incidence of Mental Health Disorders
  • Deficiency of Mental Health Professionals
  • Progress in Natural Language Processing (NLP)

Restraints

  • Data Privacy and Ethical Concerns
  • Limited Awareness and Accessibility
  • Reliability and Lack of Human Empathy

Trends

  • Integration with Telehealth Platforms
  • Use of Wearables and Digital Biomarkers
  • Personalized Therapy through AI Algorithms

Access the full forecast model.

Country-level data · Company profiles · Editable dataset · Analyst consultation included.

AI in Mental Health Market Analysis — Presence

Geographical Analysis

Click countries to explore
Loading map…

Regional and Country Analysis

Global AI in Mental Health Market Analysis 2026

Region / Country 2021 (A)2025 (A)2033 (P) CAGR
Global$ 733.73 Million$ 1740.29 Million$ 9790.31 Million24.1%
North America$ 312.57 Million$ 733.88 Million$ 4017.9 Million23.679%
United States$ 253.6 Million$ 584.34 Million$ 3119.56 Million23.29%
Canada$ 32.56 Million$ 84.08 Million$ 496.34 Million24.849%
Mexico$ 26.41 Million$ 65.45 Million$ 402.01 Million25.47%
Europe$ 132.07 Million$ 309.62 Million$ 1708.37 Million23.8%
United Kingdom$ 23.26 Million$ 57.02 Million$ 332.9 Million24.678%
France$ 17.92 Million$ 41.55 Million$ 222.21 Million23.316%
Germany$ 31.28 Million$ 75.41 Million$ 427 Million24.202%
Italy$ 12.63 Million$ 28.35 Million$ 146.01 Million22.737%
Russia$ 10.34 Million$ 23.92 Million$ 122.1 Million22.604%
Spain$ 8.51 Million$ 19.42 Million$ 104.49 Million23.415%
Sweden$ 6.99 Million$ 16.2 Million$ 85.42 Million23.102%
Denmark$ 4.57 Million$ 10.3 Million$ 55.94 Million23.555%
Switzerland$ 4.71 Million$ 10.77 Million$ 51.25 Million21.527%
Luxembourg$ 4.99 Million$ 11.57 Million$ 58.09 Million22.342%
Rest of Europe$ 6.88 Million$ 15.12 Million$ 102.96 Million27.097%
Asia Pacific$ 179.03 Million$ 439.41 Million$ 2565.06 Million24.675%
China$ 62.66 Million$ 153.89 Million$ 909.81 Million24.873%
Japan$ 36.38 Million$ 88.05 Million$ 491.98 Million23.995%
South Korea$ 14.83 Million$ 35.84 Million$ 204.02 Million24.284%
India$ 18.82 Million$ 47.81 Million$ 302.83 Million25.953%
Australia$ 13.76 Million$ 32.61 Million$ 183.15 Million24.076%
Singapore$ 6.8 Million$ 16.27 Million$ 91.99 Million24.179%
Taiwan$ 5.55 Million$ 13.42 Million$ 77.35 Million24.477%
South East Asia$ 10.62 Million$ 26.73 Million$ 166.73 Million25.715%
Rest of APACxxxxxxxxxxxxxxxx
South America$ 36.69 Million$ 84.22 Million$ 451.96 Million23.37%
Brazil$ 16.06 Million$ 36.93 Million$ 202.4 Million23.695%
Argentina$ 5.19 Million$ 11.92 Million$ 65.1 Million23.641%
Colombia$ 3.77 Million$ 8.74 Million$ 48.72 Million23.954%
Peru$ 3.29 Million$ 7.45 Million$ 38.05 Million22.604%
Chile$ 2.8 Million$ 6.28 Million$ 32.99 Million23.046%
Rest of South America$ 5.58 Million$ 12.9 Million$ 64.7 Million22.334%
Middle East$ 32.28 Million$ 77.8 Million$ 461.61 Million24.929%
Saudi Arabia$ 12.49 Million$ 29.66 Million$ 173.52 Million24.711%
Turkey$ 6.26 Million$ 14.93 Million$ 85.92 Million24.456%
UAE$ 6.23 Million$ 15.23 Million$ 95.3 Million25.765%
Egypt$ 3.68 Million$ 8.63 Million$ 50.03 Million24.572%
Qatar$ 2.16 Million$ 5.24 Million$ 31.39 Million25.084%
Rest of Middle East$ 1.45 Million$ 4.13 Million$ 25.46 Million25.545%
Africa$ 41.09 Million$ 95.37 Million$ 585.41 Million25.46%
East Africaxxxxxxxxxxxxxxxx
West Africaxxxxxxxxxxxxxxxx
North Africaxxxxxxxxxxxxxxxx
South Africa$ 18.7 Million$ 44.35 Million$ 278.24 Million25.804%

A = Actual · E = Estimated · P = Projected · 🔒 Locked values require full access. Click headers to sort.

Unlock full regional dataset →

Segmentation Analysis

Offering breakdown · Illustrative 2025 shares shown free · Full-period forecast in paid report.

Software AI in Mental Health Market Analysis
XX
Software Market Size 2025
XX %
CAGR
Locked · Full data in paid report
Services AI in Mental Health Market Analysis
XX
Services Market Size 2025
XX %
CAGR
Locked · Full data in paid report

Market size by (Illustrative, 2025)
Share distribution (2025)

Disclaimer: The charts and graphs are for illustrative purposes only and do not represent actual market values. To access accurate quantitative data, please request a paid report or request free sample.

To learn more about market share and segmentation, request the free sample pages.

Competitor Analysis

AI in Mental Health Industry News:

  • January 2022

MIT scientist Rosalind Picard collaborates with clinicians:

MIT scientist Rosalind Picard collaborated with clinicians to improve mental health. This collaboration will help to develop machine learning algorithms to facilitate diagnosis and examine symptom changes in patients. 

  • November 2022

Microsoft supports IWill with an 'AI for Accessibility' grant to develop AI CBT mental health program for 615 million

Hindi users:
India's leading mental-health platform IWill received a new grant from Microsoft's 'AI for Accessibility’ program to build its inclusive and effective Hindi-based AI Mental Health conversational program for over 615 million Hindi-language users in the world. 

Impact of the COVID-19 pandemic on AI in the mental healthcare Market:

In the initial phase of the COVID-19 pandemic, governments across several nations have imposed lockdowns resulting in limitations to stepping out, financial pressures, and social isolation. Therefore, many people had suffered from anxiety, depression, loneliness, insomnia, and sadness, and experienced stress during the pandemic which has led to an increasing number of mentally disordered patients and becomes worst the situation. 
Therefore, AI in mental healthcare played an important role during a pandemic. As it helps to identify and monitor health disorders with the purpose of providing better treatment including maintaining electronic health records and supporting physicians to understand the causes of mental disorders. Therefore, several benefits of the AI revolution in mental disorders are expected to fuel the market growth post-pandemic. 

Click any bar or cell to request the full company profile
Top Companies (In no particular order)2022 (A)2023 (A)2024 (A)2025 (A)
AiCure••• ••• ••• •••
Calmerry••• ••• ••• •••
Cognito Therapeutics••• ••• ••• •••
Flow Neuroscience••• ••• ••• •••
Mental Canvas••• ••• ••• •••
Moodpath••• ••• ••• •••
Sonde Health••• ••• ••• •••
Woebot Health••• ••• ••• •••

We Provide Regional Breakdown of this Companies and Company specific to any Country, Region, Product/ service as well. We cover market share analysis for publicly listed companies as well as privately held companies, subject to data availability.

Request company profile for validation →

Report Scope & Analysis

The global AI in Mental Health market is experiencing exponential growth, projected to expand from $733.7 million in 2021 to over $9.7 billion by 2033, driven by a remarkable CAGR of 24.1%. This surge is fueled by increasing mental health awareness, the urgent need for accessible care, and significant advancements in artificial intelligence, machine learning, and natural language processing. AI solutions, including chatbots, predictive analytics tools, and personalized therapy platforms, are becoming integral to modern mental healthcare. They offer scalable, confidential, and cost-effective support, helping to bridge the gap in traditional services. North America currently dominates the market, but the Asia Pacific region is emerging as a key growth hub due to its large population and rapid technological adoption. Despite the promising outlook, challenges related to data privacy, algorithmic bias, and regulatory hurdles must be addressed to ensure ethical and effective implementation.

Key strategic insights from our comprehensive analysis reveal:

  • North America's Dominance and High-Growth Frontiers: North America, particularly the U.S., holds the largest market share due to high technology adoption and robust venture capital funding. However, the Asia Pacific region, led by China and India, is projected to witness the fastest growth, driven by a massive user base and increasing mobile health penetration.
  • The Imperative of Ethical AI and Data Privacy: As AI systems handle highly sensitive personal data, building user trust is paramount. Companies must prioritize robust data security, transparency in algorithmic decision-making, and compliance with regulations like HIPAA and GDPR to mitigate risks of bias and privacy breaches.
  • Personalization is the Future: The market is shifting from one-size-fits-all solutions to hyper-personalized care. AI's ability to analyze individual data from wearables, journals, and conversations allows for tailored interventions, predictive risk assessments, and dynamic treatment adjustments, significantly enhancing therapeutic outcomes.

Strategic Recommendations for Manufacturers

  • Prioritize Clinical Validation and Collaboration: Forge strong partnerships with mental health professionals, researchers, and academic institutions to conduct rigorous clinical trials. Demonstrating efficacy and safety through peer-reviewed evidence is crucial for gaining credibility with both clinicians and users.
  • Champion Ethical AI and Transparency: Invest in developing transparent and explainable AI (XAI) models. Proactively address potential algorithmic biases by using diverse training data. Implement robust, best-in-class data security and privacy protocols that comply with global standards like HIPAA and GDPR to build and maintain user trust.
  • Focus on User Experience and Integration: Design intuitive, engaging, and empathetic user interfaces to drive long-term adoption. Develop seamless integration capabilities with existing healthcare ecosystems, including electronic health records (EHRs) and telehealth platforms, to position AI tools as a complementary, not replacement, part of the care continuum.
  • Develop Scalable, Culturally-Aware Solutions: To tap into high-growth emerging markets, create solutions that are multilingual, culturally sensitive, and accessible on low-bandwidth networks. A modular, platform-based approach can allow for easier customization for different regions and populations.

Introduction of AI in Mental Health

A mental disorder is a medical condition that disturbs a person’s thinking, fexeling, interest, mood, and ability for performing daily activities. Several factors such as trauma or a history of abuse, injury, genetic disorder (biological factors), physical illness, use of alcohol or drugs, generic disorder, and chemical imbalances in the brain are some of the major factors contributing to the development of mental illness. In addition, common signs of mental illness are changes in eating habits, mood swings, excessive worrying or fear, avoiding friends and social activities, and problems concentrating. 
 

Analyst Conclusion

Our study will explain complete manufacturing process along with major raw materials required to manufacture end-product. This report helps to make effective decisions determining product position and will assist you to understand opportunities and threats around the globe.

The AI in Mental Health Market Analysis is witnessing significant growth in the near future.

In 2023, the Software segment accounted for a notable share of the AI in Mental Health Market Analysis.

Supriya Yadav
Supriya Yadav Verified Analyst
Research Analyst

Purchase & Support

What you get, what it costs, and how we stand behind it

Every licence includes two years of analyst access, not just a document. Below: the decisions this research supports, what is included, what is charged separately, and the checks every figure passes before release.

Data updatedSeptember 20268th Edition · Delivery in 5–7 business days

What our consultation helps you decide

If you are deciding…

  • Whether to enter or expand in a market
  • Where to invest across the portfolio
  • Which customer groups to target
  • Where to direct product development
  • How to position against competitors
  • How your performance compares to the market
  • Whether to acquire, partner or divest
  • Whether to invest or fund
  • How to plan budgets and targets
  • Which route to market to build
  • How to assess supply and sourcing risk

These are the decisions clients bring us most often — but they are not the limit. Most engagements surface questions the data alone does not answer, and that is where the consultation does the work. Tell us what you are deciding, and our analyst will tell you what the research can support.

Included in your purchase

A licence is a two-year relationship, not a one-time download. Everything below is included at no additional cost.

Access & formats

Multi-format delivery
Cloud/HTML with master and team access, PDF, Excel data models, board-ready PPT, and the Athenaeum AI consultant.
Interactive dashboard
Toggle the dataset across global currencies and languages in real time.
Portfolio-level insight
Three-year country-level market sizing across your entire product range, not a single line.

Updates & editions

8 quarterly refreshes
Complimentary data updates every quarter for two years, so your figures track the market rather than the publication date.
Next two annual editions
The following two yearly editions are added to your account automatically.
Dated at source
Every deliverable carries a visible “data updated” date so recency is never in question.

Advisory & support

6 hours analyst consultation
One-to-one time with the lead analyst for Q&A, walkthroughs, or to join an internal executive discussion as an independent adviser.
Two-year strategic advisory
Continuing support on assumptions, methodology and evolving requirements for the full licence period.
24/7 client support
Round-the-clock account support for ad-hoc queries and new requests.

How delivery works

From first enquiry to dispatch, with a named analyst attached at every stage. Standard delivery is 5–7 business days from scope confirmation.

Before you buy

Complimentary preview. The full data structure and table of contents, so you can judge scope before committing.

Scope tailored to your question. Share your use case and problem statement and we shape the research around it.

Modular purchasing. Buy specific chapters, sections or graphs at nominal rates without the full dataset.

Confidentiality from first contact

Your proprietary requirements and personal information are safeguarded under GDPR (EU/UK), CCPA (USA) and the DPDP Act (India).

All project parameters are bound by a non-disclosure agreement from your first enquiry — not from the point of purchase.

Delivery execution

  1. 01Scope confirmationReview the preview with your dedicated analyst to agree variables, structure and formats.
  2. 02Extraction & customisationWe isolate the precise segments and parameters you need from the core database.
  3. 03Current-market validationFigures are refreshed and cross-checked against current-quarter market conditions.
  4. 04Expert QASenior specialists run qualitative checks and resolve overlaps and discrepancies.
  5. 05Dispatch & walkthroughDelivered in 5–7 business days, followed by an analyst-led walkthrough and Q&A.

Scope, timeline and price are confirmed in writing before any work starts. Customised datasets follow the same validation method and quality review as the standard report.

Available at additional cost

Outside the standard licence, but available on request. Scope and price are confirmed in writing before any work begins.

Raw interview transcriptsVerbatim records from the primary research conducted for this study, released under NDA and priced separately.
Live primary surveyNew fieldwork designed to your question, run through our B2B and B2C panel. Delivered as a standalone market survey engagement.
Extended forecast horizonProjection beyond the published forecast period, built on the same model and validation method.
Custom scope and segmentationProduct definitions, countries, competitor sets, time horizon, and metrics such as volume, price trend, import/export or TAM/SAM/SOM.
Not available at any priceThe identities of the industry experts who contribute to and validate our research are protected under non-disclosure agreement. We will describe their roles, sectors and years of experience, and an expert can join your call as an independent third party — but we do not sell or disclose names.

How we assure quality

Before any dataset is released, it passes a five-stage review carried out by senior analysts and independent industry specialists.

  1. Senior analyst reviewEvery headline figure — market size, forecast, growth rate — is checked by a senior analyst before publication.
  2. Independent expert verificationEach data point is reviewed by at least two industry specialists with 15+ years in the category.
  3. Arithmetic and reconciliationCountry and regional figures are reconciled to their totals and cross-checked against observable market conditions.
  4. Divergence resolutionWhere sources conflict, we trace the cause rather than averaging it away, and record the basis for the figure we publish.
  5. Dated releaseEach deliverable ships with an explicit data-updated date and the edition it belongs to.

By combining statistical validation with qualitative vetting by practitioners, we release figures that are structurally sound and ready to carry into a board paper, an investment memo or a regulatory filing.

Need something outside this scope? Share your use case and we will confirm feasibility, timeline and price in writing before work starts.

Frequently Asked Questions

The increasing number of suicide cases across the globe coupled with growing awareness about the mental disorder are major factors driving the market growth.
The major key players included in this market are Meru, New life solution Inc., Ginger, Lyra Health Inc., Quartet, Spring Care Inc., Talkspace Inc., mindstrong Health, Woebot Health, and Wysa LTD., among others
The study involved in-depth qualitative and quantitative analyses of the market. Moreover, the research study involves the use of secondary sources and databases such as key companies’ annual reports, paid & public databases, Bloomberg, and Factiva to identify and collect information useful for a technical and market-oriented study of the global AI in the mental healthcare market. Market value evaluation is done by using top-down as well as bottom-up analysis.
Yes, the report includes a COVID-19 impact analysis.
The report has been analysed from the year 2018 to 2030

★ Reviews


Rate this report

AI in Mental Health Market Analysis — Table of Contents

Disclaimer:
  • This is just a redacted sample pages of the actual deliverable report and only for representative purposes
  • Charts/Graphs/Numbers/data are only for Representative purposes and do not depict actual statistics.
  • The table of Contents differs according to the user License selection. Current Displayed TOC is for the Corporate User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report.
  • Specific Tables, Graphs, Sections, and Chapters can be ordered at a discounted price.
  • If applicable; On Request Volume Data will also be provided (at an Additional Cost).
Report Scope
OfferingSoftware, Services
TechnologyNatural Language Processing, Context-Aware Computing, Computer Vision, Machine Learning
DisorderAnxiety, Depression, Schizophrenia, Post-Traumatic Stress Disorder (PTSD), Insomnia, Others
End UserHospitals and Clinics, Mental Health Centers, Research Institutions, Others
List of CompetitorsAiCure, Calmerry, Cognito Therapeutics, Flow Neuroscience, Mental Canvas, Moodpath, Sonde Health, Woebot Health
  • Chapter 1. Competitor Analysis (Subject to Data Availability (Private Players))

    • 1.1 Top Competitors Analysis
      • 1.1.1 Global AI in Mental Health Market Analysis by Key Players
      • 1.1.2 Segment Market Analysis by Key Players
      • 1.1.3 Top Players Ranking 2024
      • 1.1.4 New Product Launch Analysis
      • 1.1.5 Industry Mergers and Acquisition Analysis
    • 1.2 Company Profile (Data Subject to Availability) Sample Format
      • 1.2.1 AiCure
        • 1.2.1.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.1.2 Business Overview
        • 1.2.1.3 Financials (Subject to data availability)
        • 1.2.1.4 R&D Investment (Subject to data availability)
        • 1.2.1.5 Product Types Specification
        • 1.2.1.6 Business Strategy
        • 1.2.1.7 Recent Developments
        • 1.2.1.8 Management Change
        • 1.2.1.9 S.W.O.T Analysis
      • 1.2.2 Calmerry
        • 1.2.2.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.2.2 Business Overview
        • 1.2.2.3 Financials (Subject to data availability)
        • 1.2.2.4 R&D Investment (Subject to data availability)
        • 1.2.2.5 Product Types Specification
        • 1.2.2.6 Business Strategy
        • 1.2.2.7 Recent Developments
        • 1.2.2.8 Management Change
        • 1.2.2.9 S.W.O.T Analysis
      • 1.2.3 Cognito Therapeutics
        • 1.2.3.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.3.2 Business Overview
        • 1.2.3.3 Financials (Subject to data availability)
        • 1.2.3.4 R&D Investment (Subject to data availability)
        • 1.2.3.5 Product Types Specification
        • 1.2.3.6 Business Strategy
        • 1.2.3.7 Recent Developments
        • 1.2.3.8 Management Change
        • 1.2.3.9 S.W.O.T Analysis
      • 1.2.4 Flow Neuroscience
        • 1.2.4.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.4.2 Business Overview
        • 1.2.4.3 Financials (Subject to data availability)
        • 1.2.4.4 R&D Investment (Subject to data availability)
        • 1.2.4.5 Product Types Specification
        • 1.2.4.6 Business Strategy
        • 1.2.4.7 Recent Developments
        • 1.2.4.8 Management Change
        • 1.2.4.9 S.W.O.T Analysis
      • 1.2.5 Mental Canvas
        • 1.2.5.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.5.2 Business Overview
        • 1.2.5.3 Financials (Subject to data availability)
        • 1.2.5.4 R&D Investment (Subject to data availability)
        • 1.2.5.5 Product Types Specification
        • 1.2.5.6 Business Strategy
        • 1.2.5.7 Recent Developments
        • 1.2.5.8 Management Change
        • 1.2.5.9 S.W.O.T Analysis
      • 1.2.6 Moodpath
        • 1.2.6.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.6.2 Business Overview
        • 1.2.6.3 Financials (Subject to data availability)
        • 1.2.6.4 R&D Investment (Subject to data availability)
        • 1.2.6.5 Product Types Specification
        • 1.2.6.6 Business Strategy
        • 1.2.6.7 Recent Developments
        • 1.2.6.8 Management Change
        • 1.2.6.9 S.W.O.T Analysis
      • 1.2.7 Sonde Health
        • 1.2.7.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.7.2 Business Overview
        • 1.2.7.3 Financials (Subject to data availability)
        • 1.2.7.4 R&D Investment (Subject to data availability)
        • 1.2.7.5 Product Types Specification
        • 1.2.7.6 Business Strategy
        • 1.2.7.7 Recent Developments
        • 1.2.7.8 Management Change
        • 1.2.7.9 S.W.O.T Analysis
      • 1.2.8 Woebot Health
        • 1.2.8.1 Company Basic Information, Manufacturing Base, Sales Area, and Competitors
        • 1.2.8.2 Business Overview
        • 1.2.8.3 Financials (Subject to data availability)
        • 1.2.8.4 R&D Investment (Subject to data availability)
        • 1.2.8.5 Product Types Specification
        • 1.2.8.6 Business Strategy
        • 1.2.8.7 Recent Developments
        • 1.2.8.8 Management Change
        • 1.2.8.9 S.W.O.T Analysis
  • Chapter 2. Global AI in Mental Health Market Analysis

    • 2.1 Global AI in Mental Health Market Analysis
    • 2.2 Global AI in Mental Health Market Analysis by Region
    • 2.3 Global AI in Mental Health Market Analysis by Offering
    • 2.4 Global AI in Mental Health Market Analysis by Technology
    • 2.5 Global AI in Mental Health Market Analysis by Disorder
    • 2.6 Global AI in Mental Health Market Analysis by End User
    • 2.7 Global AI in Mental Health Market Analysis by Key Players
  • Chapter 3. North America AI in Mental Health Market Analysis

    • 3.1 North America AI in Mental Health Market Analysis
    • 3.2 North America AI in Mental Health Market Analysis by Country
    • 3.3 North America AI in Mental Health Market Analysis by Offering
    • 3.4 North America AI in Mental Health Market Analysis by Technology
    • 3.5 North America AI in Mental Health Market Analysis by Disorder
    • 3.6 North America AI in Mental Health Market Analysis by End User
    • 3.7 North America AI in Mental Health Market Analysis by Key Players
  • Chapter 4. Europe AI in Mental Health Market Analysis

    • 4.1 Europe AI in Mental Health Market Analysis
    • 4.2 Europe AI in Mental Health Market Analysis by Country
    • 4.3 Europe AI in Mental Health Market Analysis by Offering
    • 4.4 Europe AI in Mental Health Market Analysis by Technology
    • 4.5 Europe AI in Mental Health Market Analysis by Disorder
    • 4.6 Europe AI in Mental Health Market Analysis by End User
    • 4.7 Europe AI in Mental Health Market Analysis by Key Players
  • Chapter 5. Asia Pacific AI in Mental Health Market Analysis

    • 5.1 Asia Pacific AI in Mental Health Market Analysis
    • 5.2 Asia Pacific AI in Mental Health Market Analysis by Country
    • 5.3 Asia Pacific AI in Mental Health Market Analysis by Offering
    • 5.4 Asia Pacific AI in Mental Health Market Analysis by Technology
    • 5.5 Asia Pacific AI in Mental Health Market Analysis by Disorder
    • 5.6 Asia Pacific AI in Mental Health Market Analysis by End User
    • 5.7 Asia Pacific AI in Mental Health Market Analysis by Key Players
  • Chapter 6. South America AI in Mental Health Market Analysis

    • 6.1 South America AI in Mental Health Market Analysis
    • 6.2 South America AI in Mental Health Market Analysis by Country
    • 6.3 South America AI in Mental Health Market Analysis by Offering
    • 6.4 South America AI in Mental Health Market Analysis by Technology
    • 6.5 South America AI in Mental Health Market Analysis by Disorder
    • 6.6 South America AI in Mental Health Market Analysis by End User
    • 6.7 South America AI in Mental Health Market Analysis by Key Players
  • Chapter 7. Middle East AI in Mental Health Market Analysis

    • 7.1 Middle East AI in Mental Health Market Analysis
    • 7.2 Middle East AI in Mental Health Market Analysis by Country
    • 7.3 Middle East AI in Mental Health Market Analysis by Offering
    • 7.4 Middle East AI in Mental Health Market Analysis by Technology
    • 7.5 Middle East AI in Mental Health Market Analysis by Disorder
    • 7.6 Middle East AI in Mental Health Market Analysis by End User
    • 7.7 Middle East AI in Mental Health Market Analysis by Key Players
  • Chapter 8. Africa AI in Mental Health Market Analysis

    • 8.1 Africa AI in Mental Health Market Analysis
    • 8.2 Africa AI in Mental Health Market Analysis by Country
    • 8.3 Africa AI in Mental Health Market Analysis by Offering
    • 8.4 Africa AI in Mental Health Market Analysis by Technology
    • 8.5 Africa AI in Mental Health Market Analysis by Disorder
    • 8.6 Africa AI in Mental Health Market Analysis by End User
    • 8.7 Africa AI in Mental Health Market Analysis by Key Players
  • Chapter 9. Offering Analysis

    • 9.1 Software
      • 9.1.1 Global Software Market
      • 9.1.2 Global Software Market by Region
    • 9.2 Services
      • 9.2.1 Global Services Market
      • 9.2.2 Global Services Market by Region
  • Chapter 10. Technology Analysis

    • 10.1 Natural Language Processing
      • 10.1.1 Global Natural Language Processing Market
      • 10.1.2 Global Natural Language Processing Market by Region
    • 10.2 Context-Aware Computing
      • 10.2.1 Global Context-Aware Computing Market
      • 10.2.2 Global Context-Aware Computing Market by Region
    • 10.3 Computer Vision
      • 10.3.1 Global Computer Vision Market
      • 10.3.2 Global Computer Vision Market by Region
    • 10.4 Machine Learning
      • 10.4.1 Global Machine Learning Market
      • 10.4.2 Global Machine Learning Market by Region
  • Chapter 11. Disorder Analysis

    • 11.1 Anxiety
      • 11.1.1 Global Anxiety Market
      • 11.1.2 Global Anxiety Market by Region
    • 11.2 Depression
      • 11.2.1 Global Depression Market
      • 11.2.2 Global Depression Market by Region
    • 11.3 Schizophrenia
      • 11.3.1 Global Schizophrenia Market
      • 11.3.2 Global Schizophrenia Market by Region
    • 11.4 Post-Traumatic Stress Disorder (PTSD)
      • 11.4.1 Global Post-Traumatic Stress Disorder (PTSD) Market
      • 11.4.2 Global Post-Traumatic Stress Disorder (PTSD) Market by Region
    • 11.5 Insomnia
      • 11.5.1 Global Insomnia Market
      • 11.5.2 Global Insomnia Market by Region
    • 11.6 Others
      • 11.6.1 Global Others Market
      • 11.6.2 Global Others Market by Region
  • Chapter 12. End User Analysis

    • 12.1 Hospitals and Clinics
      • 12.1.1 Global Hospitals and Clinics Market
      • 12.1.2 Global Hospitals and Clinics Market by Region
    • 12.2 Mental Health Centers
      • 12.2.1 Global Mental Health Centers Market
      • 12.2.2 Global Mental Health Centers Market by Region
    • 12.3 Research Institutions
      • 12.3.1 Global Research Institutions Market
      • 12.3.2 Global Research Institutions Market by Region
    • 12.4 Others
      • 12.4.1 Global Others Market
      • 12.4.2 Global Others Market by Region
  • Chapter 13. Qualitative Analysis (Subject to Data Availability)

    • 13.1 Market Drivers
    • 13.2 Market Restraints
    • 13.3 Market Trends
    • 13.4 Market Opportunity
    • 13.5 Technological Road Map (Subject to Data Availability)
    • 13.6 Product Life Cycle (Subject to Data Availability)
    • 13.7 Customer and Buyer Behavior Analysis
      • 13.7.1 Digital Engagement, Customer Experience & Relationship Analysis
      • 13.7.2 Customer Buying Behavior & Purchase Decision Analysis
      • 13.7.3 Vendor Selection, Supplier Preferences & Future Demand Trends
      • 13.7.4 Pricing, Affordability & Value Perception Analysis
      • 13.7.5 Customer Segmentation & Demand Pattern Analysis
    • 13.8 PESTEL Analysis
      • 13.8.1 Political Factors
      • 13.8.2 Economic Factors
      • 13.8.3 Social Factors
      • 13.8.4 Technological Factors
      • 13.8.5 Legal Factors
      • 13.8.6 Environmental Factors
    • 13.9 Industrial Chain Analysis (Subject to Data Availability)
      • 13.9.1 Industry Chain Analysis
      • 13.9.2 Manufacturing Cost Analysis
      • 13.9.3 Supply Side Analysis
        • 13.9.3.1 Raw Material Analysis
        • 13.9.3.2 Raw Material Procurement Analysis
        • 13.9.3.3 Raw Material Price Trend Analysis
    • 13.10 Porter’s Five Forces Analysis
      • 13.10.1 Bargaining Power of Suppliers
      • 13.10.2 Bargaining Power of Buyers
      • 13.10.3 Threat of New Entrants
      • 13.10.4 Threat of Substitutes
      • 13.10.5 Degree of Competition
    • 13.11 Patent Analysis (Subject to Data Availability)
    • 13.12 ESG Analysis
    • 13.13 Geopolitical Outlook
      • 13.13.1 Global Power Realignment & Strategic Alliances
      • 13.13.2 Geopolitical Risk Landscape & Conflict Hotspots
      • 13.13.3 International Trade Relations & Market Access Environment
      • 13.13.4 Regulatory & Policy Shifts Impacting Cross-Border Operations
      • 13.13.5 Supply Chain Resilience, Localization & Resource Nationalism
      • 13.13.6 Technology Sovereignty & Digital Geopolitics
      • 13.13.7 Strategic Implications for Investment, Growth & Market Entry
    • 13.14 AI & Market Transformation
      • 13.14.1 Competitive Landscape Disruption & Strategic Shifts
      • 13.14.2 AI-Driven Transformation of Industry Value Chain
      • 13.14.3 Evolution of Business Models & Revenue Streams
      • 13.14.4 AI-Driven Product, Service & Innovation Transformation
      • 13.14.5 Customer Behavior, AI Adoption & Future Market Evolution
  • Chapter 14. TOP 10 Country Analysis

    • 14.1 Country 1
    • 14.2 Country 2
    • 14.3 Country 3
    • 14.4 Country 4
    • 14.5 Country 5
    • 14.6 Country 6
    • 14.7 Country 7
    • 14.8 Country 8
    • 14.9 Country 9
    • 14.10 Country 10
  • Chapter 15. Research Findings

    • 15.1 Key Takeaways
    • 15.2 Analyst Point of View
    • 15.3 Assumptions and Acronyms
  • Chapter 16. Research Methodology and Sources

    • 16.1 Primary Data Collection
      • 16.1.1 Steps for Primary Data Collection
        • 16.1.1.1 Identification of KOL
      • 16.1.2 Backward Integration
      • 16.1.3 Forward Integration
      • 16.1.4 How Primary Research Help Us
      • 16.1.5 Modes of Primary Research
    • 16.2 Secondary Research
      • 16.2.1 How Secondary Research Help Us
      • 16.2.2 Sources of Secondary Research
    • 16.3 Data Validation
      • 16.3.1 Data Triangulation
    • 16.4 Data Representation

Athenaeum AI Dashboard

Research Framework · 70:30 Primary:Secondary

Our Proprietary Methodology

Cognitive Market Research and Consulting "The Full Truth" methodology — a rigorous triangulation process that combines primary research, secondary validation, and expert calibration. Implemented by Supriya Yadav and team for the AI in Mental Health Market Analysis Market analysis.

01

Primary Intelligence Gathering

Direct interviews with 50+ industry stakeholders including manufacturers, distributors, end-users, and regulatory bodies across all six regions.

02

Secondary Data Triangulation

Cross-referencing against trade databases, customs records, financial filings, patent databases, and verified industry publications.

03

Expert Validation Protocol

Each data point undergoes validation by minimum two independent domain experts with 15+ years of industry experience.

04

Athenaeum AI Processing

Our proprietary AI platform aggregates, normalizes, and identifies patterns across 10,000+ data points to surface non-obvious insights.

05

Editorial & QA Review

Final review by senior analysts ensures accuracy, coherence, and actionability of all insights and recommendations.

Data Assurance Metrics
Data Points Validated 10,400+
Expert Interviews 54
Countries Covered 39+
Company Profiles 8+
Forecast Accuracy (Historical) 94.2%
Analytical Coverage
Market Sizing Revenue Forecast CAGR Analysis Competitor Benchmarking SWOT Porter's Analysis PESTEL Value Chain ESG Analysis Tariff Impact Patent Mapping Tech Trends

To maintain the integrity of our proprietary methodology and protect our elite expert network, specific source disclosures are reserved for full-access partners. Our research framework is anchored by a 70:30 primary-to-secondary ratio, ensuring your strategy is driven by real-time market intelligence rather than recycled, publicly available, or AI-generated data. Every deliverable includes an exhaustive source directory and grants direct analyst access.

Latest News about AI in Mental Health Market

 25 Apr 2024 financialexpress.com

‘Look, Listen & Link’: Fortis launches comprehensive mental healthcare vertical; Highlights need for psychological first aid

In collaboration with United We Care, Fortis Healthcare has introduced "Adayu Mindfulness," a comprehensive vertical for mental health services. The AI-powered comprehensive mental health solution will improve people's mental health and access to care globally. Adayu will concentrate on residential in-patient mental health treatments, such as acute psychiatry, deaddiction, and rehabilitation, as well as digital tele-mental health. An estimated USD 2-3 billion is spent on mental health care in India, where 1 in 8 persons suffer from a mental illness. With the launch of Adayu, Fortis Healthcare begins a new chapter in their history as they combine clinical expertise, innovation, and artificial intelligence with the best possible treatment, all while working to increase access and raise awareness. The cutting-edge AI technology from United We Care will work in unison with Adayu's network of mental health providers. Delivering mental health care should be revolutionised with the aim of making it more inexpensive, efficient, individualised, and available to all.

Read the source

Latest Articles about AI in Mental Health Market

Sources from the Pharma and Healthcare Industry

How We Serve You

The Three Pillars of End-to-End Market Research Services

We don't just hand over data. We partner with your team across three integrated service lines — each designed to give you decision-grade intelligence on the AI in Mental Health Market Analysis market.

Service 01

Market Survey

B2B B2C

Structured primary research across both B2B and B2C channels. We design and execute custom surveys targeting manufacturers, distributors, procurement heads, and end-consumers in the ai in mental health market analysis ecosystem — validated by our global panel of 10,000+ industrial respondents.

What's Included
  • Buyer intent & sentiment analysis
  • Purchase cycle mapping
  • Price sensitivity research
  • Channel preference profiling
  • Competitive perception study
Most Requested
Service 02

Customized Market Data & Reports

Custom Ready Report

Choose from our ready-to-access 8th Edition report or commission a fully customized dataset tailored to your exact strategic questions. Cross-splits, custom geographies, proprietary segmentation — we build the intelligence asset your board actually needs.

What's Included
  • Ready syndicate report
  • Custom data scope & segmentation
  • Excel quantitative models
  • Board-ready PPT with key findings
  • Secure cloud portal access
Service 03

Strategic Consultation

With Survey With Report

Every survey and every report comes with dedicated analyst consultation. Our senior research team walks your leadership through findings, answers strategic questions in real-time, and helps translate data into your next board presentation or investment thesis.

What's Included
  • Dedicated analyst assigned to you
  • Live walkthrough of findings
  • Strategic Q&A sessions
  • Go-to-market recommendations
  • NDA-protected engagement

Customize This Report

Tell us the specific segments, regions, or companies you need — and we will tailor the deliverable to your requirements.

AI in Mental Health market size was USD 910.6 Million in 2022!